SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,247 | -25.4% | 2,953 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $13,731 | +0.6% | 2,953 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $13,643 | -43.4% | 2,953 | -0.9% | 0.00% | 0.0% |
| Q4 2022 | $24,086 | +45.6% | 2,981 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $16,545 | +742.4% | 2,981 | +690.7% | 0.00% | – |
| Q2 2022 | $1,964 | -91.9% | 377 | -87.2% | 0.00% | -100.0% |
| Q1 2022 | $24,224 | -83.4% | 2,947 | -70.0% | 0.00% | -50.0% |
| Q4 2021 | $146,315 | -39.1% | 9,833 | -22.6% | 0.00% | -33.3% |
| Q3 2021 | $240,092 | +7.3% | 12,710 | +5.6% | 0.00% | 0.0% |
| Q2 2021 | $223,656 | +13.8% | 12,031 | +39.3% | 0.00% | 0.0% |
| Q1 2021 | $196,601 | +4.8% | 8,638 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $187,531 | +116.0% | 8,638 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $86,812 | – | 8,638 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
| AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
| Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
| First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
| BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
| Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
| Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
| Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
| Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |